The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease

Autor: Gojis, O., Rudraraju, B., Alifrangis, C., Krell, J., Libalova, P., Palmieri, C.

Publikováno v: In European Journal of Surgical Oncology 2010 36(3):224-229

Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer.

Autor: Giannoudis A; Department of Molecular and Clinical Cancer Medicine, The Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK.; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Malki MI; Department of Molecular and Clinical Cancer Medicine, The Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK., Rudraraju B; Department of Molecular and Clinical Cancer Medicine, The Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK.; Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, London, UK., Mohhamed H; Cancer Early Detection Advanced Research Center, Oregon Health and Science University, Knight Cancer Institute School of Medicine, Portland, USA., Menon S; Cancer Research UK, Cambridge Research Institute, University of Cambridge, Cambridge, UK., Liloglou T; Department of Molecular and Clinical Cancer Medicine, The Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK., Ali S; Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, London, UK., Carroll JS; Cancer Research UK, Cambridge Research Institute, University of Cambridge, Cambridge, UK., Palmieri C; Department of Molecular and Clinical Cancer Medicine, The Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, L69 3GE, UK. c.palmieri@liverpool.ac.uk.; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK. c.palmieri@liverpool.ac.uk.

Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2020 Nov 16; Vol. 22 (1), pp. 126. Date of Electronic Publication: 2020 Nov 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PFDN4 as a Prognostic Marker Was Associated with Chemotherapy Resistance through CREBP1/AURKA Pathway in Triple-Negative Breast Cancer.

Autor: Wang, Shih-Ho¹ (AUTHOR), Yeh, Cheng-Hsi¹ (AUTHOR), Wu, Chia-Wei² (AUTHOR) snoopy79101@gmail.com, Hsu, Chia-Yi³ (AUTHOR) husonweihsu@hotmail.com, Tsai, Eing-Mei³ (AUTHOR), Hung, Chao-Ming⁴ (AUTHOR), Wang, Yi-Wen² (AUTHOR) ywwang0228@gmail.com, Hsieh, Tsung-Hua² (AUTHOR) ed111945@edah.org.tw

Publikováno v: International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3906. 13p.

Challenges and Opportunities of Nanomedicine: Novel Comprehensive Approaches for Brain Metastasis.

Autor: Xiang, Yufan¹ (AUTHOR), Li, Zhiqian¹ (AUTHOR), Pan, Dayi¹ (AUTHOR), Gong, Qiyong^1,2,3 (AUTHOR), Luo, Kui^1,2 (AUTHOR) luokui@scu.edu.cn, Liu, Yanhui¹ (AUTHOR) liuyh@scu.edu.cn

Publikováno v: Small Structures. Feb2024, Vol. 5 Issue 2, p1-21. 21p.